HighGravityDataSigned in · PRO
Guidance history, every release
Raised · a change from the previous releaseSame · restated unchanged— · not stated in that releaseEvery value links to its sentence in the filing
| Metric | Oct 31, 2024 FY24 Q3 | Jan 30, 2025 FY24 Q4 | May 2, 2025 FY25 Q1 | Jul 31, 2025 FY25 Q2 | Oct 30, 2025 FY25 Q3 | Feb 5, 2026 FY25 Q4 | Apr 30, 2026 FY26 Q1 | Jul 30, 2026 FY26 Q2 |
|---|---|---|---|---|---|---|---|---|
| For FY2026 | ||||||||
| Adjusted Revenues | — | — | — | — | — | New“~$280,000” | — | — |
| Adjusted revenues outlook | — | — | — | — | — | New“approximately $280.0 billion” | — | — |
| Adjusted Effective Tax Rate | — | — | — | — | — | New“~19.0%” | — | — |
| Adjusted income from operations | — | — | — | — | — | New“at least $7.950 billion, or at least $30.25 per share” | — | — |
| Adjusted Income from Operations | — | — | — | — | — | New“at least $7,950” | — | — |
| Adjusted income from operations, per share | — | — | — | — | — | New“at least $30.25 per share” | — | — |
| Adjusted Income from Operations, per share | — | — | — | — | — | — | New“at least $30.35” | Raised“at least $30.45” |
| Adjusted SG&A Expense Ratio | — | — | — | — | — | New“~5.0%” | — | — |
| Capital Expenditures | — | — | — | — | — | New“~$1,300” | — | — |
| Cash Flow from Operations | — | — | — | — | — | New“~$9,000” | — | — |
| Cigna Healthcare Adjusted Income from Operations, Pre-Tax | — | — | — | — | — | New“at least $4,500” | Raised“at least $4,525” | Raised“at least $4,550” |
| Cigna Healthcare Medical Care Ratio | — | — | — | — | — | New“83.7% to 84.7%” | Reiterated“83.7% to 84.7%” | Reiterated“83.7% to 84.7%” |
| Consolidated adjusted income from operations | — | — | — | — | — | — | — | New“at least $30.45 per share” |
| Consolidated adjusted income from operations | — | — | — | — | — | New“at least $7.950 billion” | — | — |
| Evernorth Adjusted Income from Operations, Pre-Tax | — | — | — | — | — | New“at least $6,900” | Reiterated“at least $6,900” | Reiterated“at least $6,900” |
| Quarterly dividend declared | — | — | — | — | — | New“$1.56 per share” | — | — |
| Shareholder Dividends | — | — | — | — | — | New“~$1,600” | — | — |
| The Cigna Group's outlook for full year 2026 consolidated adjusted income from operations | — | — | — | — | — | — | New“at least $30.35 per share” | — |
| Total Medical Customers | — | — | — | — | — | New“~18.1M” | — | — |
| Weighted Average Shares Outstanding (millions) | — | — | — | — | — | New“261 to 265” | — | — |
| For FY2025 | ||||||||
| Adjusted Revenues | — | New“at least $252,000” | — | — | — | — | — | — |
| Adjusted Effective Tax Rate | — | New“~19.0%” | — | — | — | — | — | — |
| Adjusted income from operations | — | New“at least $7.9 billion, or at least $29.50 per share” | — | — | — | — | — | — |
| Adjusted Income from Operations | — | New“at least $7,900” | — | — | — | — | — | — |
| Adjusted Income from Operations, per share | — | New“at least $29.50” | — | Raised“at least $29.60” | — | — | — | — |
| Adjusted Income from Operations, per share (2025 outlook) | — | — | — | — | New“at least $29.60” | — | — | — |
| Adjusted SG&A Expense Ratio | — | New“~5.4%” | — | — | — | — | — | — |
| Capital Expenditures | — | New“~$1,400” | — | — | — | — | — | — |
| Cash Flow from Operations | — | New“~$10,000” | — | — | — | — | — | — |
| Cigna Healthcare Adjusted Income from Operations, Pre-Tax | — | New“at least $4,100” | Raised“at least $4,125” | Reiterated“at least $4,125” | Reiterated“at least $4,125” | — | — | — |
| Cigna Healthcare Medical Care Ratio | — | New“83.2% to 84.2%” | Reiterated“83.2% to 84.2%” | Reiterated“83.2% to 84.2%” | Reiterated“83.2% to 84.2%” | — | — | — |
| Evernorth Adjusted Income from Operations, Pre-Tax | — | New“at least $7,200” | Reiterated“at least $7,200” | Reiterated“at least $7,200” | Reiterated“at least $7,200” | — | — | — |
| Outlook for full year 2025 consolidated adjusted income from operations, per share | — | — | New“$29.60 per share” | — | — | — | — | — |
| Shareholder Dividends | — | New“~$1,600” | — | — | — | — | — | — |
| Total Medical Customers | — | New“~18.1M” | — | — | — | — | — | — |
| Weighted Average Shares Outstanding (millions) | — | New“266 to 270” | — | — | — | — | — | — |
| For FY2024 | ||||||||
| Adjusted income from operations, per share (full year 2024 outlook) | New“at least $28.40” | — | — | — | — | — | — | — |
| Cigna Healthcare Adjusted Income from Operations, Pre-Tax | New“at least $4,775” | — | — | — | — | — | — | — |
| Cigna Healthcare Medical Care Ratio | New“81.7% to 82.5%” | — | — | — | — | — | — | — |
| Evernorth Adjusted Income from Operations, Pre-Tax | New“at least $7,000” | — | — | — | — | — | — | — |
| No period stated | ||||||||
| Incremental share repurchase authorization | — | New“$6.0 billion” | — | — | — | — | — | — |
| Quarterly dividend | — | — | — | — | — | New“$1.56 per share” | — | — |
| Quarterly dividend per share | — | New“$1.51 per share” | — | — | — | — | — | — |
| Share repurchase authorization | — | New“increase of $6.0 billion in incremental share repurchase authorization, bringing total authorization to $10.3 billion” | — | — | — | — | — | — |
| Total share repurchase authorization | — | New“$10.3 billion” | — | — | — | — | — | — |
Values in quotation marks are the company’s words. Change labels compare each statement with the same metric and target year in the previous release. HighGravityData does not judge whether guidance was met.